Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.

PLoS biology
2009
https://researcherprofiles.org/profile/1466594
19209957
Feldman ME, Apsel B, Uotila A, Loewith R, Knight ZA, Ruggero D, Shokat KM